Clindamycin Topiccal Cream/Ointment Suppliers & Bulk Manufacturers
Available Forms: Topical Creams and Ointments
Available Strengths: 1%, 2%
Reference Brands: Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)
Category:
Antibiotics
Clindamycin ointment and creams inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing bacterial growth. They effectively treat acne, skin infections, and abscesses. Benefits include targeted topical therapy, rapid relief of skin symptoms, minimal systemic absorption, and a favorable safety profile when used as directed.
Clindamycin topiccal cream/ointment is available in Topical Creams and Ointments
and strengths such as 1%, 2%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clindamycin topiccal cream/ointment is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clindamycin topiccal cream/ointment can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clindamycin ointment and creams are approved in the EU and US for treating acne and bacterial skin infections. In the EU, brands like Clindacne are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for clindamycin topical formulations, ensuring adherence to European and US standards for safe, effective dermatological therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing